Estrogen Receptor and Cytokeratin 5 Are Reliable Markers to Separate Usual Ductal Hyperplasia From Atypical Ductal Hyperplasia and Low-Grade Ductal Carcinoma in Situ

Archives of Pathology and Laboratory Medicine - United States
doi 10.5858/arpa.2015-0238-oa
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Archives of Pathology and Laboratory Medicine

Related search

Atypical Ductal Hyperplasia Bordering on Ductal Carcinoma in Situ

International Journal of Surgical Pathology
AnatomyForensic MedicinePathologySurgery
2016English

Overtreatment of Low-Grade Ductal Carcinoma in Situ

JAMA Oncology
Cancer ResearchOncology
2016English

Breast Ductal Carcinoma in Situ

International Journal of Surgical Oncology
SurgeryOncology
2012English

Ductal Carcinoma in Situ (DCIS)

European Journal of Cancer
Cancer ResearchOncology
2002English

Epidemiology of Ductal Carcinoma in Situ

Journal of the National Cancer Institute. Monographs
MedicineCancer ResearchOncology
2010English

Ductal Carcinoma in Situ (DCIS): Are We Overdetecting It?

Breast Cancer Research
Cancer ResearchOncology
2004English

Identification of Aberrant Gene Expression During Breast Ductal Carcinoma in Situ Progression to Invasive Ductal Carcinoma

Journal of International Medical Research
BiochemistryMedicineCell Biology
2019English

Different Distribution of Breast Ductal Carcinoma in Situ, Ductal Carcinoma in Situ With Microinvasion, and Invasion Breast Cancer

World Journal of Surgical Oncology
SurgeryOncology
2012English

Ductal Carcinoma in Situ of the Breast

Mayo Clinic Proceedings
Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy